Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Procept Biorobotics Corp (NQ: PRCT ) 81.11 +0.72 (+0.90%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 13, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Procept Biorobotics Corp < Previous 1 2 Next > PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 August 28, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy August 21, 2024 Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes From PROCEPT BioRobotics Via GlobeNewswire Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics? August 14, 2024 Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia Via MarketBeat Why Intuitive Surgical Stock is Dominating the Medical Sector August 06, 2024 Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However Via MarketBeat PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance August 01, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024 July 15, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy June 17, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024 June 03, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference May 13, 2024 From PROCEPT BioRobotics Via GlobeNewswire Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia May 06, 2024 Data from the Icahn School of Medicine at Mount Sinai and Potomac Urology presented at the 2024 AUA Annual Meeting highlight Aquablation therapy’s potential to become the new standard of care in BPH... From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance May 01, 2024 From PROCEPT BioRobotics Via GlobeNewswire Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia April 29, 2024 Japanese post market survey supports safety and efficacy of Aquablation therapy From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting April 23, 2024 Presentations include first published experience report of same-day discharge in an ambulatory surgical center, real-world data outcomes and 5-year data comparison between two FDA trials From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas April 04, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024 April 02, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results February 27, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston February 12, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million January 08, 2024 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City November 13, 2023 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance November 01, 2023 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023 October 16, 2023 From PROCEPT BioRobotics Via GlobeNewswire The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation October 12, 2023 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose September 20, 2023 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer September 12, 2023 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan August 22, 2023 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston August 17, 2023 From PROCEPT BioRobotics Via GlobeNewswire NorthShore University HealthSystem offers expanded access to treat most common prostate ailment August 16, 2023 Highland Park Hospital adds second AquaBeam system, Swedish Hospital installs first From PROCEPT BioRobotics; NorthShore University HealthSystem Via GlobeNewswire PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock August 01, 2023 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock August 01, 2023 From PROCEPT BioRobotics Via GlobeNewswire PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance July 27, 2023 From PROCEPT BioRobotics Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.